Patent details
EP2416765 Title: HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS
Basic Information
- Publication number:
- EP2416765
- PCT Application Number:
- PCT/US/2010/029933
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP107141269
- PCT Publication Number:
- WO/2010/117939
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- HCV INHIBITOR AND THERAPEUTIC AGENT COMBINATIONS
- French Title of Invention:
- INHIBITEUR DE VHC ET COMBINAISONS D'AGENT THÉRAPEUTIQUE
- German Title of Invention:
- KOMBINATIONEN VON HCV-INHIBITOR UND THERAPEUTISCHEN MITTELN
- SPC Number:
Dates
- Filing date:
- 05/04/2010
- Grant date:
- 30/03/2016
- EP Publication Date:
- 30/03/2016
- PCT Publication Date:
- 14/10/2010
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/02/2012
- EP B1 Publication Date:
- 30/03/2016
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 05/04/2016
- Expiration date:
- 05/04/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 05/04/2010
- Name:
- PTC Therapeutics Inc.
- Address:
- 100 Corporate Court,, South Plainfield, NJ 07080, United States (US)
Inventor
1
- Name:
- GU Zhengxian
- Address:
- United States (US)
2
- Name:
- LAHSER Frederick, C.
- Address:
- United States (US)
Priority
- Priority Number:
- 166922 P
- Priority Date:
- 22/11/1999
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 31/00;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|